يعرض 1 - 6 نتائج من 6 نتيجة بحث عن '"Sezgin Goksu, S."', وقت الاستعلام: 0.40s تنقيح النتائج
  1. 1
  2. 2
  3. 3
    Academic Journal
  4. 4
    Academic Journal

    المؤلفون: Senan, S.1 (AUTHOR), Spigel, D.R.2 (AUTHOR), Cho, B.C.3 (AUTHOR), Laktionov, K.4 (AUTHOR), Zenke, Y.5 (AUTHOR), Lee, K.H.6 (AUTHOR), Wang, Q.7 (AUTHOR), Navarro Mendivil, A.F.8 (AUTHOR), Buchmeier, E.L.9 (AUTHOR), Sezgin Goksu, S.10 (AUTHOR), Badzio, A.11 (AUTHOR), Shi, A.12 (AUTHOR), Daniel, D.B.13 (AUTHOR), Zemanova, M.14 (AUTHOR), Iyengar, P.15 (AUTHOR), Paz-Ares, L.G.16 (AUTHOR), Szadkowski, L.17 (AUTHOR), Chugh, P.18 (AUTHOR), Lai, W.C.V.19 (AUTHOR), Cheng, Y.20 (AUTHOR)

    المصدر: Annals of Oncology. 2024 Supplement 2, Vol. 35, pS1267-S1268. 2p.

    مصطلحات موضوعية: *CHEMORADIOTHERAPY, *IRRADIATION

  5. 5
    Academic Journal

    المساهمون: Institut Català de la Salut, Lim E Garvan Institute of Medical Research, St. Vincent’s Clinical School, University of New South Wales, Darlinghurst, NSW, Australia. Boyle F Mater Hospital, North Sydney, NSW, Australia. Okera M Adelaide Cancer Centre, Kurralta Park, SA, Australia. Loi S Peter MacCallum Cancer Centre, Melbourne, VI, Australia. Sezgin Goksu S Akdeniz University Medical Faculty, Antalya, Turkey. van Hal G Eli Lilly and Company, Utrecht, Netherlands. Bellet Ezquerra M Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf

    Relation: Breast Cancer Research and Treatment;195; https://doi.org/10.1007/s10549-022-06690-5; Lim E, Boyle F, Okera M, Loi S, Sezgin Goksu S, van Hal G, et al. An open label, randomized phase 2 trial assessing the impact of food on the tolerability of abemaciclib in patients with advanced breast cancer. Breast Cancer Res Treat. 2022 Oct;195:275–87.; https://hdl.handle.net/11351/8291; 000834706600001

  6. 6

    المساهمون: Institut Català de la Salut, [Lim E] Garvan Institute of Medical Research, St. Vincent’s Clinical School, University of New South Wales, Darlinghurst, NSW, Australia. [Boyle F] Mater Hospital, North Sydney, NSW, Australia. [Okera M] Adelaide Cancer Centre, Kurralta Park, SA, Australia. [Loi S] Peter MacCallum Cancer Centre, Melbourne, VI, Australia. [Sezgin Goksu S] Akdeniz University Medical Faculty, Antalya, Turkey. [van Hal G] Eli Lilly and Company, Utrecht, Netherlands. [Bellet Ezquerra M] Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus

    المصدر: Scientia

    وصف الملف: application/pdf